|
Nutrition 21, Inc. - Comparative Business Analysis Snapshot
Business Description
Nutrition 21, Inc.. The Group's principal activity is to develop market and distribute clinically substantiated nutritional supplements. These products are targeted for age and weight-related health needs, including diabetes, cardiovascular health, obesity, mental health, cognitive function and joint health. The products include Chromax which sells chromium picolinate to vitamin and supplement manufacturers and marketers and directly to retailers for its patented uses in human and animal nutrition products. The Group's trademarks include Chromax, Diachrome, Selenomax, SelenoPure, Zinmax, Zenergen and Magnemax. The Group operates in the United States.
Competitor Analysis
This analysis compares Nutrition 21, Inc. with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
